EN 
AR 
Al Razi Pharma Industry: Committed to Excellence in Saudi Pharmaceuticals
Established in 2011, Al Razi Pharma Industry is a proudly Saudi-owned pharmaceutical company dedicated to elevating healthcare in the Kingdom and across the Gulf Cooperation Council (GCC) countries. As part of the Saudi Research Group (SRG), founded in 1982, we draw on over 40 years of industry expertise and a workforce of 20,000 to deliver pharmaceutical products that meet the highest international standards.
Our company is registered and licensed under the Saudi Food and Drug Authority (SFDA) cGMP certification, along with ISO 9001:2015 and ISO 13485:2016 accreditations. This ensures that every product we manufacture adheres to rigorous quality and safety guidelines. Our focus on compliance reflects our deep commitment to enriching the lives of Saudi and GCC communities with effective, safe, and affordable healthcare solutions.
Al Razi Pharma is driven by a clear mission: to help people enjoy healthier lives by providing best-in-class pharmaceutical treatments that meet local needs while evolving to reach global markets. We are dedicated to fostering national expertise, continuously training and developing talent to support Saudi Arabia’s strategic goals of self-sufficiency in the medical industry. Our skilled and passionate team works collaboratively to exceed our clients’ expectations, ensuring that we remain at the forefront of the pharmaceutical sector.
Our vision is to be among the top pharmaceutical companies in the Saudi and GCC markets with an expanding global presence. By leveraging state-of-the-art technology and adhering to strict industry standards, we aim to deliver quality products that align with Saudi Vision 2030, which emphasizes healthcare excellence and economic diversification.
With a deep commitment to innovation, quality, and customer satisfaction, Al Razi Pharma Industry is set to become a key player in shaping the future of healthcare in the region, providing effective and affordable treatments that positively impact lives.
